Beste apotheek van Nederland

Gana T E, Quizanos L F, Castell R et al. A dose-response study
of alprostadil in patients with erectile dysfunction. Curr Ther
Res Clin Exp 1996;57(9):700-710.
Garcia-Bravo A M, Suarez-Hernandez D, Ruiz-Fernandez M A
et al. Determination of changes in blood pressure during
administration of sildenafil (Viagra) in patients with spinal cord
injury and erectile dysfunction. Proc Annu Clin Spinal Cord Inj
Conf 2006;44(5):301-308.
Ghanem H, Sherif T, bdEl-Gawad T et al. Short term use of
intracavernous vasoactive drugs in the treatment of persistent
psychogenic erectile dysfunction. Int J Impot Res
1998;10(4):211-214.
Gheorghiu S, Godschalk M, Gentili A et al. Quality of life in
patients using self-administered intracavernous injections of
prostaglandin E1 for erectile dysfunction. Br J Urol
1996;156(1):80-81.
Giammusso B, Morgia G, Spampinato A et al. Improved
pallesthetic sensitivity of pudendal nerve in impotent diabetic
patients treated with acetyl-L-carnitine. Acta Urologica Italica
1996;10(3):185-187.
Gil A, Martinez E, Oyaguez I et al. Erectile dysfunction in a
primary care setting: results of an observational, no-controlgroup,
prospective study with sildenafil under routine conditions
of use. Int J Impot Res 2001;13(6):338-347.
Gilbert H W, Gingell J C. The results of an intracorporeal
papaverine clinic. Sex Marital Ther 1991;6(1):49-56.
Gilbert H W, Gillatt D A, Desai K M et al. Intracorporeal
papaverine injection in androgen deprived men. J R Soc Med
1990;83(3):161
Gilbert R N, Graham C W, Regan J B. Double-blind- cross-over
trial of testosterone enanthate in impotent men with low or lownormal
serum testosterone levels. Br J Urol 1992;147264
Gillies H C, Roblin D, Jackson G. Coronary and systemic
hemodynamic effects of sildenafil citrate: From basic science to
clinical studies in patients with cardiovascular disease. Int J
Cardiol 2002;86(2-3):131-141.
Gingell C, Buvat J, Jardin A et al. Sildenafil citrate
(VIAGRA(TM)), an oral treatment for erectile function: 1-year,
open-label, extension studies. Int J Clin Pract 1999;(pp 30-31):­
31.
Ginsberg D L. Vardenafil treatment of sertraline-induced sexual
dysfunction. Primary Psychiatry 2004;11(11):23-24.
Ginsberg David L. Sildenafil-dihydrocodeine interaction results
in prolonged erections. [References]. Primary Psychiatry
2003;10(2):23
Giuliano F, Donatucci C, Montorsi F et al. Vardenafil
is effective and well-tolerated for treating erectile
dysfunction in a broad population of men, irrespective
of age. BJU Int 2005;95(1):110-116.
Giuliano F, Montorsi F, Mirone V et al. Switching
from intracavernous prostaglandin E1 injections to
oral sildenafil citrate in patients with erectile
dysfunction: results of a multicenter European study.
The Sildenafil Multicenter Study Group. Br J Urol
2000;164(3:Pt 1):t-11.
Giuliano F, Pena B M, Mishra A et al. Efficacy results
and quality-of-life measures in men receiving
sildenafil citrate for the treatment of erectile
dysfunction. Qual Life Res 2001;10(4):359-369.
Giuliano F, Rubio-Aurioles E, Kennelly M et al.
Efficacy and safety of vardenafil in men with erectile
dysfunction caused by spinal cord injury. Neurology
2006;66(2):210-216.
Glenn D R J, McClure N, Lewis S E M. The hidden
impact of diabetes on male sexual dysfunction and
fertility. Hum Fertil 2003;6(4):174-179.
Glina S, Sotomayor M, Gatchalian E et al. Timing of
dose relative to sexual intercourse attempt in previous
sildenafil citrate users treated with tadalafil. Br J Sex
Med 2006;3(2):309-319.
Godschalk M F, Chen J, Katz P G et al. Prostaglandin
E1 as treatment for erectile failure in elderly men. J
Am Geriatr Soc 1994;42(12):1263-1265.
Godschalk M, Gheorghiu D, Chen J et al. Long-term
efficacy of a new formulation of prostaglandin E1 as
treatment for erectile failure.. Br J Urol
1996;155(3):915-917.
Gogtay N J, Bichile S K, Pinto C J et al. Erectile
dysfunction and sildenafil citrate.[comment]. J Assoc
Physicians India 2001;49871-872.
Goldenberg M M. Safety and efficacy of sildenafil
citrate in the treatment of male erectile dysfunction.
Clin Ther. 1998;20(6):1033-1048.
Goldstein I. Oral phentolamine: an alpha-1, alpha-2
adrenergic antagonist for the treatment of erectile
dysfunction. [Review] [9 refs]. Int J Impot Res
2000;12Suppl-80.
Goldstein I. A 36-week, open label, non-comparative
study to assess the long-term safety of sildenafil citrate
(VIAGRA) in patients with erectile dysfunction. Int J
Clin Pract 1999;Supplement.102-109.
Ginzburg R, Wong Y, Fader J S. Effect of bupropion on sexual
dysfunction. Ann Pharmacother 2005;39(12):2096-2099.
D-106